Yiran Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiran Wu has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Suwen Zhao
ShanghaiTech University
10 shared publications - Fei Xu
Human Institute, ShanghaiTech University, Shanghai, China
5 shared publications - Lijie Wu
Human Institute, ShanghaiTech University, Shanghai, China
5 shared publications - Xi Lin
Human Institute, ShanghaiTech University, Shanghai, China
4 shared publications - Zhi-Jie Liu
Human Institute, ShanghaiTech University, Shanghai, China
4 shared publications Bo Chen
Human Institute, ShanghaiTech University, Pudong, China
3 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Springer Nature in Research Square
A Phospholipid Synthesis Inhibitor Protects Against Bacterial Infection
The rapid emergence of multidrug-resistant (MDR) bacteria highlights the urgent need for antibacterial agents that operate through previously unexplored mechanisms. PlsY, a seven-transmembrane glycerol-3-phosphate acyltransferase that catalyzes an essential step in bacterial phospholipid biosynthesis, represents an attractive antibacterial target. However, inhibitor development has so far focused on substrate analogues. Here, we identify Gpatin, a small-molecule inhibitor of PlsY, through structure-based virtual screening and biochemical characterization. Gpatin inhibits PlsY enzymes from multiple pathogenic bacteria and displays antibacterial activity across clinically relevant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae . Cryo-electron microscopy reveals that Gpatin binds within a partially membrane-exposed pocket formed by the C-terminal transmembrane bundle and surrounding phospholipids, overlapping the substrate-binding site and explaining its competitive inhibitory activity. Moreover, Gpatin binding induces a large-scale rearrangement of the transmembrane architecture that disrupts formation of the catalytic phosphate hole required for catalysis, thereby stabilizing PlsY in an inactive conformation. In murine infection models, Gpatin exhibits in vivo antibacterial activity against S. aureus and S. pneumoniae . Together, our findings further establish PlsY as a chemically tractable antibacterial target and reveal an unexpected conformational vulnerability that can be exploited for inhibitor development.
- 31 August 2026
- Published by Springer Nature in Research Square
Open AccessA Phospholipid Synthesis Inhibitor Protects Against Bacterial Infection
The rapid emergence of multidrug-resistant (MDR) bacteria highlights the urgent need for antibacterial agents that operate through previously unexplored mechanisms. PlsY, a seven-transmembrane glycerol-3-phosphate acyltransferase that catalyzes an essential step in bacterial phospholipid biosynthesis, represents an attractive antibacterial target. However, inhibitor development has so far focused on substrate analogues. Here, we identify Gpatin, a small-molecule inhibitor of PlsY, through structure-based virtual screening and biochemical characterization. Gpatin inhibits PlsY enzymes from multiple pathogenic bacteria and displays antibacterial activity across clinically relevant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae . Cryo-electron microscopy reveals that Gpatin binds within a partially membrane-exposed pocket formed by the C-terminal transmembrane bundle and surrounding phospholipids, overlapping the substrate-binding site and explaining its competitive inhibitory activity. Moreover, Gpatin binding induces a large-scale rearrangement of the transmembrane architecture that disrupts formation of the catalytic phosphate hole required for catalysis, thereby stabilizing PlsY in an inactive conformation. In murine infection models, Gpatin exhibits in vivo antibacterial activity against S. aureus and S. pneumoniae . Together, our findings further establish PlsY as a chemically tractable antibacterial target and reveal an unexpected conformational vulnerability that can be exploited for inhibitor development.
- Retracted
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8085) , 754-758
Crystal structures of agonist-bound human cannabinoid receptor CB1
Cannabinoid receptor 1 (CB1) is the primary target of the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC), the psychoactive constituent of marijuana1. Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB1–agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state2, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe2003.36 and Trp3566.48 (where the superscripts denote Ballesteros–Weinstein numbering3) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8085) , 754-758
RetractedCrystal structures of agonist-bound human cannabinoid receptor CB1
Cannabinoid receptor 1 (CB1) is the primary target of the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC), the psychoactive constituent of marijuana1. Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB1–agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state2, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe2003.36 and Trp3566.48 (where the superscripts denote Ballesteros–Weinstein numbering3) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
- Open Access
The 4 th GPCR Dock: assessment of blind predictions for GPCR-ligand complexes in the era of AlphaFold
The GPCR Dock competitions are a series of community-wide assessments of computational structural modeling and ligand docking for G protein-coupled receptors, a central class of drug targets in the human proteome. The assessments are designed to provide an unbiased overview of progress and to pinpoint areas in need of refinement, thus shaping and directing the development of computational modeling methodologies for GPCRs. In the footsteps of 2008, 2010, and 2013 assessments, the 4 th round (GPCR Dock 2021) featured five diverse and challenging prediction targets and coincided with the emergence of AlphaFold, the revolutionary Artificial Intelligence (AI) technology for protein structure prediction from amino acid sequences. This report summarizes the assessment results and challenges in the context of the convergent evolution of computational and experimental structure determination techniques for GPCRs. We demonstrate that thanks to the breakthroughs in AI-powered modeling, the accuracy of modern computational models of GPCR complexes with peptides can not only approach but also exceed that of low-resolution experimental structures. However, our results highlight the unwavering need for high-resolution GPCR structure determination, especially with small molecule chemicals, and for the concurrent application of physics-based and expert-guided modeling methods.
Open AccessThe 4 th GPCR Dock: assessment of blind predictions for GPCR-ligand complexes in the era of AlphaFold
The GPCR Dock competitions are a series of community-wide assessments of computational structural modeling and ligand docking for G protein-coupled receptors, a central class of drug targets in the human proteome. The assessments are designed to provide an unbiased overview of progress and to pinpoint areas in need of refinement, thus shaping and directing the development of computational modeling methodologies for GPCRs. In the footsteps of 2008, 2010, and 2013 assessments, the 4 th round (GPCR Dock 2021) featured five diverse and challenging prediction targets and coincided with the emergence of AlphaFold, the revolutionary Artificial Intelligence (AI) technology for protein structure prediction from amino acid sequences. This report summarizes the assessment results and challenges in the context of the convergent evolution of computational and experimental structure determination techniques for GPCRs. We demonstrate that thanks to the breakthroughs in AI-powered modeling, the accuracy of modern computational models of GPCR complexes with peptides can not only approach but also exceed that of low-resolution experimental structures. However, our results highlight the unwavering need for high-resolution GPCR structure determination, especially with small molecule chemicals, and for the concurrent application of physics-based and expert-guided modeling methods.
- Open Access
- 11 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Cryo-EM structure of an activated GPR4–Gs signaling complex
G protein-coupled receptor 4 (GPR4) belongs to the subfamily of proton-sensing GPCRs (psGPCRs), which detect pH changes in extracellular environment and regulate diverse physiological responses. GPR4 was found to be overactivated in acidic tumor microenvironment as well as inflammation sites, with a triad of acidic residues within the transmembrane domain identified as crucial for proton sensing. However, the 3D structure remains unknown, and the roles of other conserved residues within psGPCRs are not well understood. Here we report cryo-electron microscopy (cryo-EM) structures of active zebrafish GPR4 at both pH 6.5 and 8.5, each highlighting a distribution of histidine and acidic residues at the extracellular region. Cell-based assays show that these ionizable residues moderately influence the proton-sensing capacity of zebrafish GPR4, compared to the more significant effects of the triad residues. Furthermore, we reveal a cluster of aromatic residues within the orthosteric pocket that may propagate the signaling to the intercellular region via repacking the aromatic patch at the central region. This study provides a framework for future signaling and functional investigation of psGPCRs.
- 11 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Open AccessCryo-EM structure of an activated GPR4–Gs signaling complex
G protein-coupled receptor 4 (GPR4) belongs to the subfamily of proton-sensing GPCRs (psGPCRs), which detect pH changes in extracellular environment and regulate diverse physiological responses. GPR4 was found to be overactivated in acidic tumor microenvironment as well as inflammation sites, with a triad of acidic residues within the transmembrane domain identified as crucial for proton sensing. However, the 3D structure remains unknown, and the roles of other conserved residues within psGPCRs are not well understood. Here we report cryo-electron microscopy (cryo-EM) structures of active zebrafish GPR4 at both pH 6.5 and 8.5, each highlighting a distribution of histidine and acidic residues at the extracellular region. Cell-based assays show that these ionizable residues moderately influence the proton-sensing capacity of zebrafish GPR4, compared to the more significant effects of the triad residues. Furthermore, we reveal a cluster of aromatic residues within the orthosteric pocket that may propagate the signaling to the intercellular region via repacking the aromatic patch at the central region. This study provides a framework for future signaling and functional investigation of psGPCRs.
- Top Cited Papers
- 22 May 2024
- Published by Springer Nature in Nature
- Vol. 631 (8020) , 459-466
Bitter taste TAS2R14 activation by intracellular tastants and cholesterol
Bitter taste receptors, particularly TAS2R14, play central roles in discerning a wide array of bitter substances, ranging from dietary components to pharmaceutical agents1,2. TAS2R14 is also widely expressed in extra-gustatory tissues, suggesting its additional roles in diverse physiological processes and potential therapeutic applications3. Here, we present cryo-electron microcopy structures of TAS2R14 in complex with aristolochic acid, flufenamic acid and compound 28.1, coupling with different G protein subtypes. Uniquely, a cholesterol molecule is observed occupying what is typically an orthosteric site in class A GPCRs. The three potent agonists bind, individually, to the intracellular pockets, suggesting a distinct activation mechanism for this receptor. Comprehensive structural analysis, combined with mutagenesis, and molecular dynamic simulations studies, illuminate the receptor’s broad-spectrum ligand recognition and activation via intricate multiple ligand-binding sites. Additionally, our study uncovers the specific coupling modes of TAS2R14 with gustducin and Gi1 proteins. These findings should be instrumental in advancing our knowledge underlying bitter taste perception and its broader implications in sensory biology and drug discovery.
- 22 May 2024
- Published by Springer Nature in Nature
- Vol. 631 (8020) , 459-466
Top Cited PapersBitter taste TAS2R14 activation by intracellular tastants and cholesterol
Bitter taste receptors, particularly TAS2R14, play central roles in discerning a wide array of bitter substances, ranging from dietary components to pharmaceutical agents1,2. TAS2R14 is also widely expressed in extra-gustatory tissues, suggesting its additional roles in diverse physiological processes and potential therapeutic applications3. Here, we present cryo-electron microcopy structures of TAS2R14 in complex with aristolochic acid, flufenamic acid and compound 28.1, coupling with different G protein subtypes. Uniquely, a cholesterol molecule is observed occupying what is typically an orthosteric site in class A GPCRs. The three potent agonists bind, individually, to the intracellular pockets, suggesting a distinct activation mechanism for this receptor. Comprehensive structural analysis, combined with mutagenesis, and molecular dynamic simulations studies, illuminate the receptor’s broad-spectrum ligand recognition and activation via intricate multiple ligand-binding sites. Additionally, our study uncovers the specific coupling modes of TAS2R14 with gustducin and Gi1 proteins. These findings should be instrumental in advancing our knowledge underlying bitter taste perception and its broader implications in sensory biology and drug discovery.
- Open Access
- 2 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (5) , eadj7500
Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8
The human CC chemokine receptor 8 (CCR8) is an emerging therapeutic target for cancer immunotherapy and autoimmune diseases. Understanding the molecular recognition of CCR8, particularly with nonpeptide ligands, is valuable for drug development. Here, we report three cryo–electron microscopy structures of human CCR8 complexed with G i trimers in the ligand-free state or activated by nonpeptide agonists LMD-009 and ZK 756326. A conserved Y 1.39 Y 3.32 E 7.39 motif in the orthosteric binding pocket is shown to play a crucial role in the chemokine and nonpeptide ligand recognition. Structural and functional analyses indicate that the lack of conservation in Y114 3.33 and Y172 4.64 among the CC chemokine receptors could potentially contribute to the selectivity of the nonpeptide ligand binding to CCR8. These findings present the characterization of the molecular interaction between a nonpeptide agonist and a chemokine receptor, aiding the development of therapeutics targeting related diseases through a structure-based approach.
- 2 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (5) , eadj7500
Open AccessUnveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8
The human CC chemokine receptor 8 (CCR8) is an emerging therapeutic target for cancer immunotherapy and autoimmune diseases. Understanding the molecular recognition of CCR8, particularly with nonpeptide ligands, is valuable for drug development. Here, we report three cryo–electron microscopy structures of human CCR8 complexed with G i trimers in the ligand-free state or activated by nonpeptide agonists LMD-009 and ZK 756326. A conserved Y 1.39 Y 3.32 E 7.39 motif in the orthosteric binding pocket is shown to play a crucial role in the chemokine and nonpeptide ligand recognition. Structural and functional analyses indicate that the lack of conservation in Y114 3.33 and Y172 4.64 among the CC chemokine receptors could potentially contribute to the selectivity of the nonpeptide ligand binding to CCR8. These findings present the characterization of the molecular interaction between a nonpeptide agonist and a chemokine receptor, aiding the development of therapeutics targeting related diseases through a structure-based approach.
- Open Access
- 5 January 2024
- Published by Springer Nature in Cell Discovery
- Vol. 10 (1) , 1-17
A framework for Frizzled-G protein coupling and implications to the PCP signaling pathways
The ten Frizzled receptors (FZDs) are essential in Wnt signaling and play important roles in embryonic development and tumorigenesis. Among these, FZD6 is closely associated with lens development. Understanding FZD activation mechanism is key to unlock these emerging targets. Here we present the cryo-EM structures of FZD6 and FZD3 which are known to relay non-canonical planar cell polarity (PCP) signaling pathways as well as FZD1 in their G protein-coupled states and in the apo inactive states, respectively. Comparison of the three inactive/active pairs unveiled a shared activation framework among all ten FZDs. Mutagenesis along with imaging and functional analysis on the human lens epithelial tissues suggested potential crosstalk between the G-protein coupling of FZD6 and the PCP signaling pathways. Together, this study provides an integrated understanding of FZD structure and function, and lays the foundation for developing therapeutic modulators to activate or inhibit FZD signaling for a range of disorders including cancers and cataracts.
- 5 January 2024
- Published by Springer Nature in Cell Discovery
- Vol. 10 (1) , 1-17
Open AccessA framework for Frizzled-G protein coupling and implications to the PCP signaling pathways
The ten Frizzled receptors (FZDs) are essential in Wnt signaling and play important roles in embryonic development and tumorigenesis. Among these, FZD6 is closely associated with lens development. Understanding FZD activation mechanism is key to unlock these emerging targets. Here we present the cryo-EM structures of FZD6 and FZD3 which are known to relay non-canonical planar cell polarity (PCP) signaling pathways as well as FZD1 in their G protein-coupled states and in the apo inactive states, respectively. Comparison of the three inactive/active pairs unveiled a shared activation framework among all ten FZDs. Mutagenesis along with imaging and functional analysis on the human lens epithelial tissues suggested potential crosstalk between the G-protein coupling of FZD6 and the PCP signaling pathways. Together, this study provides an integrated understanding of FZD structure and function, and lays the foundation for developing therapeutic modulators to activate or inhibit FZD signaling for a range of disorders including cancers and cataracts.
- Open Access
- 27 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Structural insights into the human niacin receptor HCA2-Gi signalling complex
The hydroxycarboxylic acid receptor 2 (HCA2) agonist niacin has been used as treatment for dyslipidemia for several decades albeit with skin flushing as a common side-effect in treated individuals. Extensive efforts have been made to identify HCA2 targeting lipid lowering agents with fewer adverse effects, despite little being known about the molecular basis of HCA2 mediated signalling. Here, we report the cryo-electron microscopy structure of the HCA2-Gi signalling complex with the potent agonist MK-6892, along with crystal structures of HCA2 in inactive state. These structures, together with comprehensive pharmacological analysis, reveal the ligand binding mode and activation and signalling mechanisms of HCA2. This study elucidates the structural determinants essential for HCA2 mediated signalling and provides insights into ligand discovery for HCA2 and related receptors.
- 27 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Open AccessStructural insights into the human niacin receptor HCA2-Gi signalling complex
The hydroxycarboxylic acid receptor 2 (HCA2) agonist niacin has been used as treatment for dyslipidemia for several decades albeit with skin flushing as a common side-effect in treated individuals. Extensive efforts have been made to identify HCA2 targeting lipid lowering agents with fewer adverse effects, despite little being known about the molecular basis of HCA2 mediated signalling. Here, we report the cryo-electron microscopy structure of the HCA2-Gi signalling complex with the potent agonist MK-6892, along with crystal structures of HCA2 in inactive state. These structures, together with comprehensive pharmacological analysis, reveal the ligand binding mode and activation and signalling mechanisms of HCA2. This study elucidates the structural determinants essential for HCA2 mediated signalling and provides insights into ligand discovery for HCA2 and related receptors.
- Open Access
- 13 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Cryo-EM structures of orphan GPR21 signaling complexes
GPR21 is a class-A orphan G protein-coupled receptor (GPCR) and a potential therapeutic target for type 2 diabetes and other metabolic disorders. This receptor shows high basal activity in coupling to multiple G proteins in the absence of any known endogenous agonist or synthetic ligand. Here, we present the structures of ligand-free human GPR21 bound to heterotrimeric miniGs and miniG15 proteins, respectively. We identified an agonist-like motif in extracellular loop 2 (ECL2) that occupies the orthosteric pocket and promotes receptor activation. A side pocket that may be employed as a new ligand binding site was also uncovered. Remarkably, G protein binding is accommodated by a flexible cytoplasmic portion of transmembrane helix 6 (TM6) which adopts little or undetectable outward movement. These findings will enable the design of modulators for GPR21 for understanding its signal transduction and exploring opportunity for deorphanization.
- 13 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Open AccessCryo-EM structures of orphan GPR21 signaling complexes
GPR21 is a class-A orphan G protein-coupled receptor (GPCR) and a potential therapeutic target for type 2 diabetes and other metabolic disorders. This receptor shows high basal activity in coupling to multiple G proteins in the absence of any known endogenous agonist or synthetic ligand. Here, we present the structures of ligand-free human GPR21 bound to heterotrimeric miniGs and miniG15 proteins, respectively. We identified an agonist-like motif in extracellular loop 2 (ECL2) that occupies the orthosteric pocket and promotes receptor activation. A side pocket that may be employed as a new ligand binding site was also uncovered. Remarkably, G protein binding is accommodated by a flexible cytoplasmic portion of transmembrane helix 6 (TM6) which adopts little or undetectable outward movement. These findings will enable the design of modulators for GPR21 for understanding its signal transduction and exploring opportunity for deorphanization.
- Top Cited Papers
- 16 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6612) , 1298-1304
Structural basis for strychnine activation of human bitter taste receptor TAS2R46
Taste sensing is a sophisticated chemosensory process, and bitter taste perception is mediated by type 2 taste receptors (TAS2Rs), or class T G protein–coupled receptors. Understanding the detailed molecular mechanisms behind taste sensation is hindered by a lack of experimental receptor structures. Here, we report the cryo–electron microscopy structures of human TAS2R46 complexed with chimeric mini–G protein gustducin, in both strychnine-bound and apo forms. Several features of TAS2R46 are disclosed, including distinct receptor structures that compare with known GPCRs, a new “toggle switch,” activation-related motifs, and precoupling with mini–G protein gustducin. Furthermore, the dynamic extracellular and more-static intracellular parts of TAS2R46 suggest possible diverse ligand-recognition and activation processes. This study provides a basis for further exploration of other bitter taste receptors and their therapeutic applications.
- 16 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6612) , 1298-1304
Top Cited PapersStructural basis for strychnine activation of human bitter taste receptor TAS2R46
Taste sensing is a sophisticated chemosensory process, and bitter taste perception is mediated by type 2 taste receptors (TAS2Rs), or class T G protein–coupled receptors. Understanding the detailed molecular mechanisms behind taste sensation is hindered by a lack of experimental receptor structures. Here, we report the cryo–electron microscopy structures of human TAS2R46 complexed with chimeric mini–G protein gustducin, in both strychnine-bound and apo forms. Several features of TAS2R46 are disclosed, including distinct receptor structures that compare with known GPCRs, a new “toggle switch,” activation-related motifs, and precoupling with mini–G protein gustducin. Furthermore, the dynamic extracellular and more-static intracellular parts of TAS2R46 suggest possible diverse ligand-recognition and activation processes. This study provides a basis for further exploration of other bitter taste receptors and their therapeutic applications.